Search

Filters

Clear Filters
8:40 AM - 8:50 AM PT

192 - A Novel Therapeutic Approach Using ENO1-specific CAR-NK Cells to Target KRAS-Mutated Cancers
Speaker: Chao, K.S. Clifford, MD - China Medical University, Taiwan, Taichung, Taichung
10:45 AM - 10:55 AM PT

193 - Quality of life results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Yu, James, MD, FASTRO, MHS - Dartmouth Hitchcock Medical Center, Lebanon, NH
10:55 AM - 11:05 AM PT

194 - Daily Online Adaptive Recontouring for Prostate Cancer Using 1.5 Tesla Magnetic Resonance Image Guidance (MRgRT) Improves Patient Reported Urinary Symptoms, A Prospective, International, Observational Cohort Study (NCT04075305)
Speaker: Hall, William, MD - Medical College of Wisconsin, Elm Grove, WI
11:05 AM - 11:15 AM PT

195 - Long-Term Toxicity and Patient-Reported Quality of Life after Prostate IMRT with or without Biodegradable Balloon Rectal Spacer: Analysis of a Pivotal Randomized Trial
Speaker: Song, Daniel, MD - Johns Hopkins University, Baltimore, MD
11:15 AM - 11:25 AM PT

196 - A Randomized, Parallel Phase II Trial of Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer with Pelvic and/or Para-aortic Lymph Node Involvement Following Primary Localized Treatment with Radiotherapy
Speaker: Davis, Brian, MD, PhD - Mayo Clinic, Rochester, MN
11:25 AM - 11:35 AM PT

197 - Hydrogel Spacer Quality Assurance (QA) in a Multi-Center Randomized Control Trial of Neurovascular-Sparing SAbR for Localized Prostate Cancer (PCa)
Speaker: Desai, Neil, MD - University of Texas Southwestern Medical Center, Dallas, TX
11:35 AM - 11:45 AM PT

198 - Patient-Reported Outcomes in a Randomized Trial of <sup>18</sup>F-Fluciclovine vs<sup>68</sup>Ga-PSMA-11 PET/CT-Guided Post-Prostatectomy Radiation with Simultaneous Integrated Boosts
Speaker: Dhere, Vishal, MD - Emory University, Atlanta, GA
10:45 AM - 10:55 AM PT

199 - Improved Progression-Free and Overall Survival with Radiotherapy Consolidation Post-Autologous Stem Cell Transplant in Patients with Relapsed/Refractory Aggressive Lymphoma with Pre-Transplant Partial Metabolic Response on FDG-PET
Speaker: Abeyakoon, Chathuri, MBBS - Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON
1:40 PM - 1:50 PM PT

2 - Bladder Adjuvant RadioTherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial
Speaker: Murthy, Vedang, MD - Tata Memorial Centre, New Mumbai, Maharashtra
10:55 AM - 11:05 AM PT

200 - TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma
Speaker: Deshane, Alok, MD - MSKCC, New York, NY
2:30 PM - 4:00 PM PT

2000 - Intrafractional Motion Analysis of Pancreatic Tumors and Organs-at-Risk during MRgART Using Optical Flow Calculation
Speaker: Adachi, Takanori, PhD - Kyoto University, Kyoto, Kyoto
2:30 PM - 4:00 PM PT

2001 - Evaluation of Salivary Gland Mouse and Human Model for Small-Scale Monte Carlo Radiopharmaceutical Therapy Dosimetry
Speaker: Adam, David, PhD, MS - Johns Hopkins University School of Medicine, Baltimore, MD